基本信息
浏览量:1
职业迁徙
个人简介
As Director of the Wilmot Cancer Institute, I seek to provide the highest level of compassionate care for patients, ensuring access to novel treatments and clinical trials whenever possible. My background brings the entire continuum of lymphoma experience to patients, from diagnosis through all treatments including autologous stem cell transplantation, CAR-T cell interventions, novel agents, and survivorship.
We have built an incredibly strong team in Rochester to care for patients with lymphoma that is absolutely first rate and internationally recognized. We have expertise in hematopathology, radiation oncology, dermatology, and neurology, in addition to hematology and medical oncology. Driving this team toward excellence – and seeing our success – is highly rewarding.
研究兴趣
论文共 28 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Hematological Oncologyno. S2 (2023): 156-158
引用0浏览0引用
0
0
Hematological Oncologyno. S2 (2023): 116-117
引用0浏览0引用
0
0
Daniel O. Persky,Hongli Li, Deborah M. Stephens,Steven I. Park,Nancy L. Bartlett,Lode J. Swinnen,Paul M. Barr, Jerome D. Winegarden,Louis S. Constine,Thomas J. Fitzgerald,John P. Leonard,Brad S. Kahl,
Clinical Cancer Researchno. 6 (2019): 1718-1726
引用7浏览0引用
7
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn